Immunic, Inc.IMUXNASDAQ
LOADING
|||
Cash Flow Under Pressure
Trending lower, below historical average, modest growth trend.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-85.03M
↓ 54% below average
Average (9y)
$-55.31M
Historical baseline
Range
High:$-28.60M
Low:$-85.03M
CAGR
+5.6%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-85.03M | -19.5% |
| 2023 | $-71.16M | -9.1% |
| 2022 | $-65.26M | +21.7% |
| 2021 | $-83.30M | -80.0% |
| 2020 | $-46.27M | -61.8% |
| 2019 | $-28.60M | +34.6% |
| 2018 | $-43.76M | -6.5% |
| 2017 | $-41.08M | -13.1% |
| 2016 | $-36.33M | +30.5% |
| 2015 | $-52.29M | - |